AZI23’UTR Is a New SLC6A3 Downregulator Associated with an Epistatic Protection Against Substance Use Disorders

Kefu Liu, Jinlong Yu, Juan Zhao, Yanhong Zhou, Nian Xiong, Jie Xu, Tao Wang, Richard Bell, Hong Qing, Zhicheng Lin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Regulated activity of SLC6A3, which encodes the human dopamine transporter (DAT), contributes to diseases such as substance abuse disorders (SUDs); however, the exact transcription mechanism remains poorly understood. Here, we used a common genetic variant of the gene, intron 1 DNP1B sequence, as bait to screen and clone a new transcriptional activity, AZI23′UTR, for SLC6A3. AZI23′UTR is a 3′ untranslated region (3′UTR) of the human 5-Azacytidine Induced 2 gene (AZI2) but appeared to be transcribed independently of AZI2. Found to be present in both human cell nuclei and dopamine neurons, this RNA was shown to downregulate promoter activity through a variant-dependent mechanism in vitro. Both reduced RNA density ratio of AZI23′UTR/AZI2 and increased DAT mRNA levels were found in ethanol-naive alcohol-preferring rats. Secondary analysis of dbGaP GWAS datasets (Genome-Wide Association Studies based on the database of Genotypes and Phenotypes) revealed significant interactions between regions upstream of AZI23′UTR and SLC6A3 in SUDs. Jointly, our data suggest that AZI23′UTR confers variant-dependent transcriptional regulation of SLC6A3, a potential risk factor for SUDs.

Original languageEnglish (US)
Pages (from-to)1-12
Number of pages12
JournalMolecular Neurobiology
DOIs
StateAccepted/In press - Oct 5 2017

Fingerprint

Azacitidine
Substance-Related Disorders
Dopamine Plasma Membrane Transport Proteins
Genome-Wide Association Study
Genes
RNA
Dopaminergic Neurons
3' Untranslated Regions
Cell Nucleus
Introns
Ethanol
Down-Regulation
Clone Cells
Genotype
Alcohols
Databases
Phenotype
Messenger RNA

Keywords

  • Allele-dependent
  • Dopamine transporter
  • Kangaroo layout of genes
  • lncRNA
  • Ribonucleic repressor
  • Transcription factor

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

AZI23’UTR Is a New SLC6A3 Downregulator Associated with an Epistatic Protection Against Substance Use Disorders. / Liu, Kefu; Yu, Jinlong; Zhao, Juan; Zhou, Yanhong; Xiong, Nian; Xu, Jie; Wang, Tao; Bell, Richard; Qing, Hong; Lin, Zhicheng.

In: Molecular Neurobiology, 05.10.2017, p. 1-12.

Research output: Contribution to journalArticle

Liu, Kefu ; Yu, Jinlong ; Zhao, Juan ; Zhou, Yanhong ; Xiong, Nian ; Xu, Jie ; Wang, Tao ; Bell, Richard ; Qing, Hong ; Lin, Zhicheng. / AZI23’UTR Is a New SLC6A3 Downregulator Associated with an Epistatic Protection Against Substance Use Disorders. In: Molecular Neurobiology. 2017 ; pp. 1-12.
@article{15eca0ab3d274f1e833be340aff63774,
title = "AZI23’UTR Is a New SLC6A3 Downregulator Associated with an Epistatic Protection Against Substance Use Disorders",
abstract = "Regulated activity of SLC6A3, which encodes the human dopamine transporter (DAT), contributes to diseases such as substance abuse disorders (SUDs); however, the exact transcription mechanism remains poorly understood. Here, we used a common genetic variant of the gene, intron 1 DNP1B sequence, as bait to screen and clone a new transcriptional activity, AZI23′UTR, for SLC6A3. AZI23′UTR is a 3′ untranslated region (3′UTR) of the human 5-Azacytidine Induced 2 gene (AZI2) but appeared to be transcribed independently of AZI2. Found to be present in both human cell nuclei and dopamine neurons, this RNA was shown to downregulate promoter activity through a variant-dependent mechanism in vitro. Both reduced RNA density ratio of AZI23′UTR/AZI2 and increased DAT mRNA levels were found in ethanol-naive alcohol-preferring rats. Secondary analysis of dbGaP GWAS datasets (Genome-Wide Association Studies based on the database of Genotypes and Phenotypes) revealed significant interactions between regions upstream of AZI23′UTR and SLC6A3 in SUDs. Jointly, our data suggest that AZI23′UTR confers variant-dependent transcriptional regulation of SLC6A3, a potential risk factor for SUDs.",
keywords = "Allele-dependent, Dopamine transporter, Kangaroo layout of genes, lncRNA, Ribonucleic repressor, Transcription factor",
author = "Kefu Liu and Jinlong Yu and Juan Zhao and Yanhong Zhou and Nian Xiong and Jie Xu and Tao Wang and Richard Bell and Hong Qing and Zhicheng Lin",
year = "2017",
month = "10",
day = "5",
doi = "10.1007/s12035-017-0781-2",
language = "English (US)",
pages = "1--12",
journal = "Molecular Neurobiology",
issn = "0893-7648",
publisher = "Humana Press",

}

TY - JOUR

T1 - AZI23’UTR Is a New SLC6A3 Downregulator Associated with an Epistatic Protection Against Substance Use Disorders

AU - Liu, Kefu

AU - Yu, Jinlong

AU - Zhao, Juan

AU - Zhou, Yanhong

AU - Xiong, Nian

AU - Xu, Jie

AU - Wang, Tao

AU - Bell, Richard

AU - Qing, Hong

AU - Lin, Zhicheng

PY - 2017/10/5

Y1 - 2017/10/5

N2 - Regulated activity of SLC6A3, which encodes the human dopamine transporter (DAT), contributes to diseases such as substance abuse disorders (SUDs); however, the exact transcription mechanism remains poorly understood. Here, we used a common genetic variant of the gene, intron 1 DNP1B sequence, as bait to screen and clone a new transcriptional activity, AZI23′UTR, for SLC6A3. AZI23′UTR is a 3′ untranslated region (3′UTR) of the human 5-Azacytidine Induced 2 gene (AZI2) but appeared to be transcribed independently of AZI2. Found to be present in both human cell nuclei and dopamine neurons, this RNA was shown to downregulate promoter activity through a variant-dependent mechanism in vitro. Both reduced RNA density ratio of AZI23′UTR/AZI2 and increased DAT mRNA levels were found in ethanol-naive alcohol-preferring rats. Secondary analysis of dbGaP GWAS datasets (Genome-Wide Association Studies based on the database of Genotypes and Phenotypes) revealed significant interactions between regions upstream of AZI23′UTR and SLC6A3 in SUDs. Jointly, our data suggest that AZI23′UTR confers variant-dependent transcriptional regulation of SLC6A3, a potential risk factor for SUDs.

AB - Regulated activity of SLC6A3, which encodes the human dopamine transporter (DAT), contributes to diseases such as substance abuse disorders (SUDs); however, the exact transcription mechanism remains poorly understood. Here, we used a common genetic variant of the gene, intron 1 DNP1B sequence, as bait to screen and clone a new transcriptional activity, AZI23′UTR, for SLC6A3. AZI23′UTR is a 3′ untranslated region (3′UTR) of the human 5-Azacytidine Induced 2 gene (AZI2) but appeared to be transcribed independently of AZI2. Found to be present in both human cell nuclei and dopamine neurons, this RNA was shown to downregulate promoter activity through a variant-dependent mechanism in vitro. Both reduced RNA density ratio of AZI23′UTR/AZI2 and increased DAT mRNA levels were found in ethanol-naive alcohol-preferring rats. Secondary analysis of dbGaP GWAS datasets (Genome-Wide Association Studies based on the database of Genotypes and Phenotypes) revealed significant interactions between regions upstream of AZI23′UTR and SLC6A3 in SUDs. Jointly, our data suggest that AZI23′UTR confers variant-dependent transcriptional regulation of SLC6A3, a potential risk factor for SUDs.

KW - Allele-dependent

KW - Dopamine transporter

KW - Kangaroo layout of genes

KW - lncRNA

KW - Ribonucleic repressor

KW - Transcription factor

UR - http://www.scopus.com/inward/record.url?scp=85030669702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030669702&partnerID=8YFLogxK

U2 - 10.1007/s12035-017-0781-2

DO - 10.1007/s12035-017-0781-2

M3 - Article

C2 - 28983843

AN - SCOPUS:85030669702

SP - 1

EP - 12

JO - Molecular Neurobiology

JF - Molecular Neurobiology

SN - 0893-7648

ER -